{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:57:38Z","timestamp":1790906258073,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["EY14231"],"award-info":[{"award-number":["EY14231"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.xops.2026.101167","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:03:37Z","timestamp":1774339417000},"page":"101167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN)"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-3828","authenticated-orcid":false,"given":"Andrew J.","family":"Barkmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu P.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7726-9508","authenticated-orcid":false,"given":"Michael","family":"Elman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5495-3526","authenticated-orcid":false,"given":"Crystal A.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Glassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0886-3658","authenticated-orcid":false,"given":"Lee M.","family":"Jampol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne T.","family":"Labriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2996-3025","authenticated-orcid":false,"given":"Thanos","family":"Papakostas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2631-7754","authenticated-orcid":false,"given":"Hani","family":"Salehi-Had","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0735-849X","authenticated-orcid":false,"given":"Cynthia R.","family":"Stockdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0171-4538","authenticated-orcid":false,"given":"Wei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon R.","family":"Constantine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian B.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dara","family":"Dombrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone S.","family":"Dupre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal A.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Galusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Glassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Grose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Huggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britney","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia R.","family":"Stockdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu P.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2026.101167_bib1","doi-asserted-by":"crossref","first-page":"P66","DOI":"10.1016\/j.ophtha.2019.09.025","article-title":"Diabetic Retinopathy Preferred Practice Pattern\u00ae","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101167_bib2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","volume":"372","author":"Wells","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xops.2026.101167_bib3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2026.101167_bib4","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema","volume":"121","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101167_bib5","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","article-title":"Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"Elman","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101167_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101167_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ICU.0b013e328338679a","article-title":"Complications of intravitreal injections","volume":"21","author":"Sampat","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.xops.2026.101167_bib8","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1167\/iovs.17-22816","article-title":"Enhanced expression of NLRP3 inflammasome-related inflammation in diabetic retinopathy","volume":"59","author":"Chen","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101167_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbagen.2017.11.015","article-title":"The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release","volume":"1862","author":"Mugisho","year":"2018","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.xops.2026.101167_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12886-022-02439-2","article-title":"Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum \u2013 a systematic review","volume":"22","author":"Kuo","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.xops.2026.101167_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108384","article-title":"Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy","volume":"202","author":"Louie","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2026.101167_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/aos.13427","article-title":"NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy","volume":"95","author":"Loukovaara","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.xops.2026.101167_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/ijms22010298","article-title":"Tonabersat inhibits connexin43 hemichannel opening and inflammasome activation in an in vitro retinal epithelial cell model of diabetic retinopathy","volume":"22","author":"Lyon","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2026.101167_bib14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/14728222.2019.1673368","article-title":"Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease","volume":"23","author":"Mugisho","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.xops.2026.101167_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/09273948.2020.1811350","article-title":"Dysregulation of the NLRP3 inflammasome in diabetic retinopathy and potential therapeutic targets","volume":"30","author":"Raman","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.xops.2026.101167_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115569","article-title":"Targeting the NLRP3 inflammasome in diabetic retinopathy: from pathogenesis to therapeutic strategies","volume":"212","author":"Yang","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.xops.2026.101167_bib17","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in diabetic retinopathy","volume":"14","author":"Zheng","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.xops.2026.101167_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4103\/0301-4738.111184","article-title":"Intraocular soluble intracellular adhesion molecule-1 correlates with subretinal fluid height of diabetic macular edema","volume":"62","author":"Zhu","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101167_bib19","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.3390\/ijms24043876","article-title":"Orally delivered connexin43 hemichannel blocker, tonabersat, inhibits vascular breakdown and inflammasome activation in a mouse model of diabetic retinopathy","volume":"24","author":"Mugisho","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2026.101167_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13311-019-00786-5","article-title":"Connexin hemichannel block using orally delivered tonabersat improves outcomes in animal models of retinal disease","volume":"17","author":"Mat Nor","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.xops.2026.101167_bib21","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1167\/iovs.12-10290","article-title":"Retinal thickness in people with diabetes and minimal or no diabetic retinopathy: heidelberg spectralis optical coherence tomography","volume":"53","author":"Chalam","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101167_bib22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0161-6420(13)38009-9","article-title":"Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101167_bib23","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1177\/0962280216683570","article-title":"Should multiple imputation be the method of choice for handling missing data in randomized trials?","volume":"27","author":"Sullivan","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.xops.2026.101167_bib24","series-title":"Clinical Trials With Missing Data: A Guide for Practitioners","author":"O\u2019Kelly","year":"2014"},{"key":"10.1016\/j.xops.2026.101167_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3102\/10769986025001060","article-title":"On the adaptive control of the false discovery rate in multiple testing with independent statistics","volume":"25","author":"Benjamini","year":"2000","journal-title":"J Educ Behav Stat"},{"key":"10.1016\/j.xops.2026.101167_bib26","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2019.5790","article-title":"Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity: a randomized clinical trial","volume":"321","author":"Baker","year":"2019","journal-title":"JAMA"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526001053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526001053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:34:35Z","timestamp":1782948875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526001053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666914526001053"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101167","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN)","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Academy of Ophthalmology, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101167"}}